SRS165524 SAMN00203910 9606 Homo sapiens This is a colon cancer sample from a male patient. The cancer was defined as a CIMP tumor by satisfying the criteria of having DNA methylation at CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1, harboring BRAF mutation, and is microsatellite unstable. SRS165523 SAMN00203909 9606 Homo sapiens This is a colon cancer sample from a male patient. The cancer was defined as a CIMP tumor by satisfying the criteria of having DNA methylation at CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1, harboring BRAF mutation, and is microsatellite unstable. SRS165522 SAMN00203908 9606 Homo sapiens This is a colon cancer sample from a male patient. The cancer was defined as a CIMP tumor by satisfying the criteria of having DNA methylation at CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1, harboring BRAF mutation, and is microsatellite unstable. SRS165521 SAMN00203907 9606 Homo sapiens This is a colon cancer sample from a male patient. The cancer was defined as a non-CIMP tumor by satisfying the criteria of having no DNA methylation at CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1, harboring KRAS mutation, and is microsatellite stable. SRS165520 SAMN00203906 9606 Homo sapiens This is a colon cancer sample from a male patient. The cancer was defined as a non-CIMP tumor by satisfying the criteria of having no DNA methylation at CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1, harboring KRAS mutation, and is microsatellite stable. SRS165519 SAMN00203905 9606 Homo sapiens This is a colon cancer sample from a male patient. The cancer was defined as a non-CIMP tumor by satisfying the criteria of having no DNA methylation at CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1, harboring KRAS mutation, and is microsatellite stable. SRS161436 SAMN00199822 9606 SRS161435 SAMN00199821 9606 SRS161433 SAMN00199819 9606